SinghSSinghHLoftusEVJrPardiDS. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12(3):382–393.e1: quiz e22.
2.
BarnesELBeeryRMSchulmanARMcCarthyEPKorzenikJRWinterRW. Hospitalizations for acute myocardial infarction are decreased among patients with inflammatory bowel disease using a nationwide inpatient database. Inflamm Bowel Dis. 2016;22(9):2229–2237.
3.
MaharshakNArbelYBornsteinNM. Inflammatory bowel disease is not associated with increased intimal media thickening. Am J Gastroenterol. 2007;102(5):1050–1055.
4.
TheocharidouETellisCCMavroudiM. Lipoprotein-associated phospholipase A2 and arterial stiffness evaluation in patients with inflammatory bowel diseases. J Crohns Colitis. 2014;8(9):936–944.
5.
TheocharidouEGossiosTDGioulemeOAthyrosVGKaragiannisA. Carotid intima-media thickness in patients with inflammatory bowel disease: a systematic review. Angiology. 2014;65(4):284–293.
6.
KahlenbergJMKaplanMJ. Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus. Annu Rev Med. 2013;64:249–263.
7.
TsigkasGDavlourosPDespotopoulosSAssimakopoulosSTheocharisGHahalisG. Inflammatory bowel disease: a potential risk factor for coronary artery disease?Angiology. 2017;68(10):845–849.
8.
PurnakTYukselO. Overview of venous thrombosis in inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(5):1195–1203.
9.
MiehslerWReinischWValicE. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?Gut. 2004;53(4):542–548.
10.
HaCMagowanSAccorttNAChenJStoneCD. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol. 2009;104(6):1445–1451.
11.
MutluBErmeydanCMEncF. Acute myocardial infarction in a young woman with severe ulcerative colitis. Int J Cardiol. 2002;83(2):183–185.
12.
GraingeMJWestJCardTR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375(9715):657–663.
13.
BollenLVande CasteeleNPeetersM. The occurrence of thrombosis in inflammatory bowel disease is reflected in the clot lysis profile. Inflamm Bowel Dis. 2015;21(11):2540–2548.
14.
SpannaglMDickAFolwacznyCSchrammWLoeschkeK. Factor V Leiden mutation in patients with inflammatory bowel disease. Gastroenterology. 1999;117(1):280.
15.
CorradoERizzoMTantilloR. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke. 2006;37(2):482–486.
16.
HarbordMAnneseVVavrickaSR. The First European Evidence-Based Consensus on Extra-Intestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis. 2016;10(3):239–254.
17.
CosnesJ. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol. 2004;18(3):481–496.
18.
SeversMMangenMJvan der ValkME. Smoking is associated with higher disease-related costs and lower health-related quality of life in inflammatory bowel disease. J Crohns Colitis. 2017;11(3):342–352.
19.
MartinJKaneSVFeaginsLA. Fertility and contraception in women with inflammatory bowel disease. Gastroenterol Hepatol (NY). 2016;12(2):101–109.
